Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Polymeric nanoparticles (NPs) are particles within the size range from 1 to 1000 nm and can be loaded with active compounds entrapped within or surface-adsorbed onto the polymeric core. The term “nanoparticle” stands for both nanocapsules and nanospheres, which are distinguished by the morphological structure. Polymeric NPs have shown great potential for targeted delivery of drugs for the treatment of several diseases. In this review, we discuss the most commonly used methods for the production and characterization of polymeric NPs, the association efficiency of the active compound to the polymeric core, and the in vitro release mechanisms. As the safety of nanoparticles is a high priority, we also discuss the toxicology and ecotoxicology of nanoparticles to humans and to the environment.
Top-30
Journals
|
10
20
30
40
50
60
70
|
|
|
Pharmaceutics
64 publications, 5.15%
|
|
|
Journal of Drug Delivery Science and Technology
46 publications, 3.7%
|
|
|
Polymers
27 publications, 2.17%
|
|
|
International Journal of Molecular Sciences
26 publications, 2.09%
|
|
|
Pharmaceuticals
22 publications, 1.77%
|
|
|
BioNanoScience
18 publications, 1.45%
|
|
|
Molecules
17 publications, 1.37%
|
|
|
International Journal of Pharmaceutics
17 publications, 1.37%
|
|
|
International Journal of Nanomedicine
13 publications, 1.05%
|
|
|
AAPS PharmSciTech
12 publications, 0.97%
|
|
|
Nanomaterials
12 publications, 0.97%
|
|
|
Drug Delivery and Translational Research
11 publications, 0.88%
|
|
|
Journal of Controlled Release
11 publications, 0.88%
|
|
|
Nanomedicine
10 publications, 0.8%
|
|
|
Expert Opinion on Drug Delivery
10 publications, 0.8%
|
|
|
European Journal of Pharmaceutics and Biopharmaceutics
10 publications, 0.8%
|
|
|
Journal of Nanobiotechnology
9 publications, 0.72%
|
|
|
Colloids and Surfaces B: Biointerfaces
9 publications, 0.72%
|
|
|
Functionalized Smart Nanomaterials for Point-of-Care Testing
9 publications, 0.72%
|
|
|
Heliyon
8 publications, 0.64%
|
|
|
Advanced Drug Delivery Reviews
8 publications, 0.64%
|
|
|
International Journal of Biological Macromolecules
8 publications, 0.64%
|
|
|
European Polymer Journal
7 publications, 0.56%
|
|
|
Small
7 publications, 0.56%
|
|
|
Beilstein Journal of Nanotechnology
6 publications, 0.48%
|
|
|
Current Medicinal Chemistry
6 publications, 0.48%
|
|
|
Current Drug Delivery
6 publications, 0.48%
|
|
|
Applied Sciences (Switzerland)
6 publications, 0.48%
|
|
|
ACS Omega
6 publications, 0.48%
|
|
|
10
20
30
40
50
60
70
|
Publishers
|
50
100
150
200
250
300
350
400
|
|
|
Elsevier
357 publications, 28.72%
|
|
|
MDPI
238 publications, 19.15%
|
|
|
Springer Nature
216 publications, 17.38%
|
|
|
Wiley
75 publications, 6.03%
|
|
|
Taylor & Francis
71 publications, 5.71%
|
|
|
Bentham Science Publishers Ltd.
50 publications, 4.02%
|
|
|
American Chemical Society (ACS)
44 publications, 3.54%
|
|
|
Royal Society of Chemistry (RSC)
44 publications, 3.54%
|
|
|
Frontiers Media S.A.
28 publications, 2.25%
|
|
|
IOP Publishing
7 publications, 0.56%
|
|
|
IGI Global
7 publications, 0.56%
|
|
|
Beilstein-Institut
6 publications, 0.48%
|
|
|
A and V Publications
6 publications, 0.48%
|
|
|
IntechOpen
5 publications, 0.4%
|
|
|
Hindawi Limited
4 publications, 0.32%
|
|
|
Walter de Gruyter
4 publications, 0.32%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
4 publications, 0.32%
|
|
|
Oxford University Press
3 publications, 0.24%
|
|
|
Medknow
3 publications, 0.24%
|
|
|
EDP Sciences
3 publications, 0.24%
|
|
|
Begell House
2 publications, 0.16%
|
|
|
AIP Publishing
2 publications, 0.16%
|
|
|
Thomas Telford
2 publications, 0.16%
|
|
|
Trans Tech Publications
2 publications, 0.16%
|
|
|
PeerJ
2 publications, 0.16%
|
|
|
The University of Jordan
2 publications, 0.16%
|
|
|
Pleiades Publishing
2 publications, 0.16%
|
|
|
SAGE
2 publications, 0.16%
|
|
|
Mary Ann Liebert
1 publication, 0.08%
|
|
|
50
100
150
200
250
300
350
400
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.